IPEC e-newsletter - Excipients Insight April/May 2018 - 15-05-18

 

Inside this issue

     

Report on first 2018 IPEC Europe Board meeting

by Adrian Bone - Senior Advisor to IPEC Europe

In March, The IPEC Europe Board held its first face-to-face meeting of 2017 and here are some highlights.  After the presentation made at the Annual General Meeting in Bordeaux, now is when the real work starts and so time was spent reviewing the objectives agreed there, that they are assigned with timelines and (Board) owners, and are adequately funded. As a reminder, you can see in the infographic below our main goals for this year defining the activities required to keep IPEC Europe on track with the vison outlined in our agenda Agenda 2020. An easy reminder of what we have to do this year!

It is good to note particularly that in the areas of communication and knowledge sharing, great steps have already been taken. The website redesign is underway with a 'go live' date aimed at Q2. External events feature strongly again in the IPEC Europe, extending our outreach in a bid to ‘spread the word’ on excipients both virtually through our webinar programme and be present at several events including Making Pharmaceuticals (Brussels (March) / Coventry (April)), ExcipientFest Asia (Beijing, July) and the APV/IPEC Europe Conference (Cologne, September). We hope very much that these efforts support member recruitment, too.

Another key focus area where initiatives are ongoing is stakeholder collaboration. The collaboration with EFCG in 2017 delivered out IPEC infographic (link) and will continue to develop key messages on the importance of the upstream part of the medicines supply chain and the value it deliver. Already progressing well, following its announcement earlier this year, is the partnership with PDA to publish a ‘how to …’ guide on risk assessment for appropriate excipient GMP. And while in its early stages, our relationship with APIC will hopefully produce some good work products.   

Regulation and Harmonisation were represented as the Board reviewed the recent proposals the structures of the Pharmacopoeial Review & Harmonisation and Quality & Regulatory Affairs Committees. Both now have a two-tier structure in place, with a core team and an observer community, and seem to be functioning satisfactory but this way of working will continue to be monitored. One of the biggest challenges for each committee is to enhance their monitoring capabilities to be sure all appropriate new and revised information are evaluated to best represent the inputs of IPEC Europe members. The revitalised PR&HC is picking up core team members but the Chair position is still vacant and needs to be addressed. PR&HC and QRAC did meet in April, reports of which will be included in a future edition of Excipients Insight.   

Finally, the Election of Officers following the AGM took place as is required by our Articles of Association.

IPEC Federation update

IPEC Europe Board agendas routinely include an update on the work plan of the IPEC Federation which on this occasion was delivered by its new vice President, Frank Milek, who is now IPEC Europe’s representative on the Federation Board. The objectives presented by the incoming President, Priscilla Zawislak at the IPEC Europe AGM in Bordeaux, were discussed in the context of IPED Europe’s role in them.

If you have any questions or would like to know more about IPEC Europe Board activities, please do not hesitate to contact IPEC Europe at info@ipec-europe.org.

 

 

 

Copyright © 2005 - 2018 IPEC Europe - International Pharmaceutical Excipients Council